John P. Plastaras, MD, PhD

home / authors / john-p-plastaras-md-phd

Articles

$The Evolving Role of Radiation Therapy in DLBCL: From Early-Stage to Refractory Disease$

The Evolving Role of Radiation Therapy in DLBCL: From Early-Stage to Refractory Disease

Gavin Jones, MD;John P. Plastaras, MD, PhD;Andrea K. Ng, MD, MPH;Chris R. Kelsey, MD

December 21st 2022

Gavin Jones, MD, and colleagues explore the landscape of radiation therapy in diffuse large B-cell lymphoma.

ACR Appropriateness Criteria® Localized Nodal Indolent Lymphoma

Bradford S. Hoppe, MD, MPH;David C. Hodgson, MD;Ranjana H. Advani, MD;Bouthaina S. Dabaja, MD;Christopher R. Flowers, MD, MS;Chul Soo Ha, MD;Monika L. Metzger, MD;John P. Plastaras, MD, PhD;Kenneth B. Roberts, MD;Ronald Shapiro, MD;Stephanie A. Terezakis, MD;Karen M. Winkfield, MD, PhD;Anas Younes, MD;Louis S. Constine, MD

August 15th 2013

The present guidelines review epidemiology, pathology, presentation, workup, staging, prognostic factors, and treatment options for patients with localized nodal indolent lymphoma, with an emphasis on radiation guidelines, including radiation dose, field design, and radiation techniques.